The Society of Gynecologic Oncology of Canada

To improve the care of women with or at risk of gynecologic cancer by raising standards of practice, encouraging ongoing research, promoting innovation in prevention, care and discovery, and advancing awareness. GOC also seeks to disseminate knowledge to practitioners, patients and the general public on gynecologic cancer as well as cooperate with other organizations committed to women’s health care, oncology, and related fields.​​

https://www.gyneoncology.ca

Contact us

This is a past event. Registration is closed. View other The Society of Gynecologic Oncology of Canada events.

Event Details

Welcome to the 24th CPD!

Dear Esteemed Colleagues,


It is with great pleasure that I extend a warm welcome to all participants of The Society of Gynecologic Oncology of Canada (GOC) Continuing Professional Development (CPD) event May 2 & 3.


As we gather for this occasion, I am honored to address you as the President of our esteemed society. These past years have been marked by dedication, collaboration, and a shared commitment to advancing the field of gynecologic oncology. I am immensely proud of the strides we have made together.


This CPD event promises to be a momentous occasion, filled with insightful discussions, cutting-edge presentations, and unparalleled networking opportunities. Our esteemed lineup of speakers and experts will provide invaluable insights into the latest advancements, fostering an environment of continuous learning and professional growth.


As we collectively embark on this final leg of my presidency, I am filled with gratitude for the unwavering support and dedication of our members. It has been an incredible journey, and I am confident that the GOC will continue to flourish under new leadership.

I encourage you all to actively engage in the sessions, share your experiences, and forge new connections that will undoubtedly contribute to the enhancement of our practice and, more importantly, the well-being of the patients we serve.


May these two days be a celebration of our achievements, a testament to our shared commitment to excellence, and a catalyst for future advancements in gynecologic oncology.


Thank you for being a part of the GOC community. I look forward to cherishing these moments with you and leaving a legacy as we continue our collective pursuit of excellence in women's health.


Warm regards,


Dr. Alon Altman

President, The Society of Gynecologic Oncology of Canada

Welcome to the 24th CPD event in Toronto. Let the journey begin!

  

Ladies and gentlemen, esteemed colleagues, and healthcare professionals, welcome to the upcoming CPD event in the bustling city of Toronto! As we prepare to embark on the 24th edition of this esteemed conference, we are thrilled to announce an exceptional lineup of speakers and topics that promise to inspire, educate, and ignite meaningful dialogue.

With their collective expertise spanning various disciplines within healthcare, they are poised to deliver insightful discussions that will undoubtedly shape the future of our profession.

Throughout the conference, attendees will have the opportunity to explore a diverse range of topics, each meticulously selected to address pressing challenges and opportunities in contemporary healthcare. From gaining valuable insights into the intricate processes of Drug Funding and Health Technology Assessment to exploring groundbreaking advancements in Mirvetuximab and Antibody-Drug Conjugates, our program is designed to provide attendees with actionable strategies and innovative solutions to enhance patient care and drive positive outcomes.

Moreover, we are proud to feature sessions dedicated to addressing critical issues such as Delivering Healthcare to Indigenous Communities and Menopause Treatment for Cancer Patients. By shining a spotlight on these important topics, we reaffirm our commitment to fostering inclusivity, equity, and excellence in healthcare delivery.

In addition to our keynote presentations, attendees can look forward to an engaging session on Molecular Biology, offering a deep dive into the fascinating world of cellular mechanisms and genetic research that underpins modern medicine.

As we gather together for this momentous event, I encourage each of you to embrace the spirit of collaboration, curiosity, and continuous learning. Let us seize this unparalleled opportunity to exchange ideas, forge new connections, and collectively shape the future of healthcare.

On behalf of the organizing committee, I extend my sincerest gratitude to our speakers, sponsors, and attendees for your unwavering support and dedication to advancing excellence in healthcare education. Together, let us embark on this journey with enthusiasm and determination, as we strive to make a meaningful impact in the lives of patients and communities worldwide.

Objectives:


  1. Knowledge Dissemination: To facilitate the dissemination of cutting-edge knowledge, research findings, and best practices in various areas of healthcare, including drug funding processes, health technology assessment, novel treatment modalities, and healthcare delivery to underserved populations.
  2. Professional Development: To provide attendees with opportunities for professional development, skill enhancement, and career advancement through engaging presentations, workshops, and networking sessions led by esteemed experts and thought leaders in the field.
  3. Collaboration and Networking: To foster collaboration, networking, and knowledge exchange among attendees, speakers, and healthcare stakeholders, with the aim of fostering interdisciplinary collaboration and innovation in healthcare delivery and patient care.
  4. Inspiration and Innovation: To inspire attendees with the latest advancements, research breakthroughs, and innovative approaches in healthcare, sparking creativity, curiosity, and a commitment to continuous improvement and innovation in their respective fields.
  5. Equity and Inclusion: To promote equity, diversity, and inclusion within the healthcare community by addressing topics such as delivering healthcare to indigenous communities and menopause treatment for cancer patients, and by providing a platform for diverse voices and perspectives to be heard and valued.
  6. Professional Excellence: To support and promote professional excellence among attendees by offering high-quality, evidence-based educational content, fostering critical thinking, and encouraging lifelong learning and self-improvement in the pursuit of excellence in patient care and healthcare delivery.
  7. Impact and Transformation: To empower attendees to make a meaningful impact and drive positive transformation in their respective healthcare settings, communities, and beyond, by equipping them with the knowledge, skills, and inspiration needed to effect positive change and improve healthcare outcomes for all

Agenda

  • May 2, 2024

  • May 3, 2024

May 2, 2024

CPD Meeting

10:30 - 12:00
Strategic Check In Executives
Belgravia Room
12:00 - 13:30
Executive Meeting and Lunch
Belgravia Room
13:30 - 15:00
Pragmatic Trials Planning Meeting
Belgravia Room
18:00 - 19:30
CoP Meetings with Dinner
Immunotherapy – Off Site

BRCA – Windsor B

Obesity - Belgravia Room

Fellows Educational Course - Sovereign Ballroom

11:30 - 12:00
Registration
12:30 - 13:30
Top 2023 Papers
Sovereign Ballroom
13:30 - 14:30
Q/A Panel
Sovereign Ballroom
14:30 - 15:00
Break

Molecular Biology Course - Sovereign Ballroom

15:00 - 15:10
Introduction with Dr. Mark Carey
The objective for this symposium is to discuss current, relevant, molecular and cell biology discoveries, highlighting how these insights impact our comprehension of the pathogenesis and treatment of cancer. The goal is to provide engaging and enlightening presentations geared to clinicians with a view to broaden their knowledge of the basic science of cancer as it relates to the prevention, detection and treatment of cancer. Key historical advances that have shaped our approach to cancer are of interest. For the 2024 symposium we are highlighting the field of cancer biomarkers. Relating the course material to the research interests of our speakers is most welcome.

Speakers are encouraged to discuss novel scientific advances that will shape the future of cancer treatment and our comprehension of cancer biology, paying particular attention to advances in therapeutic targets and markers of therapeutic response in the era of personalized medicine. We encourage the speakers to highlight how advancements in basic science lead to specific improvements in personalized cancer care as a means of motivating the target audience to learn more about translational science. We hope that this symposium will provide opportunity for trainees and clinicians to further their interest in relevant aspects of basic and translational research and encourage their involvement in research initiatives and clinical trials for their patients.

For accreditation purposes we need 25% interaction time with the audience members.  This can be accomplished by inserting general but relevant questions as part of your presentation to encourage audience interaction.  You may also design specific questions following your talk to solicit feedback from attendees. If you would like to do this, please send 2-3 questions to our GOC National Manager Cidalia Sluce (csluce@gyneoncology.ca).

The talks for this year’s course are scheduled for 20-25 minutes with 5-10 minutes for questions. Please feel free to call me if you have any questions. Thank-you so much and we look forward to seeing you. We have had an exceptional registration response so there is lots of interest!
Dr. Mark Carey (Gynecologic Oncologist at Vancouver General Hospital and BC Cancer)
Dr. Mark Carey
15:10 - 15:40
MMR deficiency and other immune biomarkers with Dr. Melica Brodeur
1) Review the molecular biology and history of MMRd and immune biomarkers in Gynecological Cancers.
2) Discuss recent advances using biomarkers to treat patients with endometrial cancer.
3) Discuss novel biomarker research in rare ovarian cancers.
4) Review the role of biomarker testing in the management of Gyn Cancers.
Dr. Melica Nourmoussavi Brodeur (Assistant Professor at Department of Obstetrics & Gynecology and the Department of Oncology at McGill University)
Dr. Melica Nourmoussavi Brodeur
15:40 - 16:10
Biomarkers for prognosis and prediction of hormone responsiveness in low-grade serous ovarian carcinomas with Dr. Nelson Wong
1) Review and explore the current biomarkers for antihormone efficacy for the treatment of ovarian and endometrial cancers.
2) Discuss the limitations of ER/PR as predictive biomarkers.
3) Review the evolving comprehension of biomarkers of hormone responsiveness in cancer.
4) Discuss novel experimental approaches to describe predictive biomarkers in low-grade serous ovarian carcinomas.
Dr. Nelson Wong (Staff Scientist at BC Cancer)
Dr. Nelson Wong
16:10 - 16:40
ct DNA (HPV) as a prognostic and predictive biomarker in HPV-related Cervical Carcinoma with Dr. Kathy Han
1) Review the use of ctDNA to detect subclinical disease.
2) Discuss the use of ctDNA as a prognostic biomarker in cervix carcinoma.
3) Discuss the use of ctDNA to guide clinical trial design inHPV-related cervix cancers
4) Discuss the future role of HPV ctDNA in the management of cervix.
Dr. Kathy Han (Associate Professor at University of Toronto)
Dr. Kathy Han
16:40 - 16:50
Wrap Up Discussion with Dr. Mark Carey
Sovereign Ballroom
Dr. Mark Carey (Gynecologic Oncologist at Vancouver General Hospital and BC Cancer)
Dr. Mark Carey
17:00 - 18:00
Biology Course/Fellow Reception
Lobby Lounge

Fellows Half-Day

Fellows Educational Course

The Society of Gynecologic Oncology of Canada is pleased to invite you to the fifth Fellows Educational Course. Accomplished gynecologic oncologists will discuss topics relevant to fellows, residents, and early-career attendings.


This Fellows Educational Course promises to be an amazing in-person session!

Molecular Biology for Gynecologic Cancers Course

Molecular Biology Course


The objective for this symposium is to discuss current, relevant, molecular and cell biology discoveries, highlighting how these insights impact our understanding of the pathogenesis and treatment of cancer. The goal is to provide engaging and enlightening presentations geared to clinicians with a view to broaden their knowledge of the basic science of cancer as it relates to the prevention, detection and treatment of cancer. Key historical advances that have shaped our approach to cancer are of interest. For the 2024 symposium we are highlighting the field of cancer biomarkers. Relating the course material to the research interests of our speakers is most welcome.


Speakers are encouraged to discuss novel scientific advances that will shape the future of cancer treatment and our understanding of cancer biology, paying particular attention to advances in therapeutic targets and markers of therapeutic response in the era of personalized medicine. We encourage the speakers to highlight how advancements in basic science lead to specific improvements in personalized cancer care as a means of motivating the target audience to learn more about translational science. We hope that this symposium will provide opportunity for trainees and clinicians to further their interest in relevant aspects of basic and translational research and encourage their involvement in research initiatives and clinical trials for their patients.


For accreditation purposes we need 25% interaction time with the audience members. This can be accomplished by inserting general but relevant questions as part of your presentation to encourage audience interaction. You may also design specific questions following your talk to solicit feedback from attendees. If you would like to do this, please send 2-3 questions to our GOC National Manager Cidalia Sluce (csluce@gyneoncology.ca).


The talks for this year's course are scheduled for 20-25 minutes with 5-10 minutes for questions. Please feel free to call me if you have any questions. Thank-you so much and we look forward to seeing you. We have had an exceptional registration response so there is lots of interest!

Speakers & Moderators

Dr. Alon Altman (Professor, Gynecologic Oncology at University of Manitoba, Cancercare Manitoba)

Dr. Alon Altman

Professor, Gynecologic Oncology at University of Manitoba, Cancercare Manitoba

Arrow Big Smoke (Indigenous Cancer Patient Navigator at Cancer Care Alberta)

Arrow Big Smoke

Indigenous Cancer Patient Navigator at Cancer Care Alberta

Dr. Melica Nourmoussavi Brodeur (Assistant Professor at Department of Obstetrics & Gynecology and the Department of Oncology at McGill University)

Dr. Melica Nourmoussavi Brodeur

Assistant Professor at Department of Obstetrics & Gynecology and the Department of Oncology at McGill University

Dr. Mandy Buss (Indigenous Health Lead at Northern Connections Medical Center)

Dr. Mandy Buss

Indigenous Health Lead at Northern Connections Medical Center

Dr. Mark Carey (Gynecologic Oncologist at Vancouver General Hospital and BC Cancer)

Dr. Mark Carey

Gynecologic Oncologist at Vancouver General Hospital and BC Cancer

Dr. Vanessa Carlson (Gynecologic Oncologist at Juravinski Hospital and Cancer Centre)

Dr. Vanessa Carlson

Gynecologic Oncologist at Juravinski Hospital and Cancer Centre

Dr. Marc Geirnaert (Director of Provincial Oncology Drug Program at CancerCare Manitoba)

Dr. Marc Geirnaert

Director of Provincial Oncology Drug Program at CancerCare Manitoba

Dr. Kathy Han (Associate Professor at University of Toronto)

Dr. Kathy Han

Associate Professor at University of Toronto

Dr. Michelle Jacobson (Menopause Specialist at Women’s College and Mount Sinai Hospitals)

Dr. Michelle Jacobson

Menopause Specialist at Women’s College and Mount Sinai Hospitals

Dr. Brent Jim (Assistant Professor at Division of Oncology & Department of Gynecology)

Dr. Brent Jim

Assistant Professor at Division of Oncology & Department of Gynecology

Dr. Sarah Kean (Gynecologic Oncologist)

Dr. Sarah Kean

Gynecologic Oncologist

Gabriel Levin (Fellow in Gynecologic Oncology at McGill University)

Gabriel Levin

Fellow in Gynecologic Oncology at McGill University

Katie McRae (Fellow at University of British Columbia)

Katie McRae

Fellow at University of British Columbia

Cristina Mitric

Cristina Mitric

Dr. Katie Moore (Deputy Director of OU Health Stephenson Cancer Center)

Dr. Katie Moore

Deputy Director of OU Health Stephenson Cancer Center

Dr. Miguel Russo (Staff Physician at Mount Sinai Fertility)

Dr. Miguel Russo

Staff Physician at Mount Sinai Fertility

Dr. Stephanie Snow (Medical Oncologist at QEII Hospital)

Dr. Stephanie Snow

Medical Oncologist at QEII Hospital

Dr. Nelson Wong (Staff Scientist at BC Cancer)

Dr. Nelson Wong

Staff Scientist at BC Cancer

Thank you for registering. Note that the listed price does not include taxes. HST will be added at the end of your checkout as the event takes place in Toronto, ON. Early bird prices will be available until April 3rd, 2024 at 11:55pm EST.


Cancellation and refund policy

All registration fees are non-refundable. 


Questions regarding the event? Email us at enquiry@gyneoncology.ca.

GOC member physicians-CPD Friday only

Member PriceCAD $475

GOC member fellows-CPD Friday only

Member PriceCAD $285

Other GOC members-CPD Friday only

Member PriceCAD $220

Retired GOC members-CPD Friday only

Member PriceCAD $125

Medical students-CPD Friday only

Public PriceCAD $165

Sponsor and partners-CPD Friday only

*This fee is for additional registrants outside the sponsorship complimentary registrations.*

Public PriceCAD $605

Member conference dinner

Member PriceCAD $150

Non-member conference dinner

Public PriceCAD $200

Non-member physicians-CPD Friday only

Public PriceCAD $605

Non-member fellows-CPD Friday only

Public PriceCAD $305

Other non-members-CPD Friday only

Public PriceCAD $290

Non member Opening reception at Omni-Drinks only after the fellows half day

Public PriceCAD $50

Fellows half day, Thursday only-GOC member fellows

Member PriceCAD $100

Fellows half day, Thursday only-GOC member physicians

Member PriceCAD $110

Fellows half day, Thursday only-Other GOC members

Member PriceCAD $105

Fellows half day, Thursday only-Non-member fellows

Public PriceCAD $110

Fellows half day, Thursday only-Non GOC member physicians

Public PriceCAD $130

Fellows half day, Thursday only-Other non GOC members

Public PriceCAD $115

Fellows half day, Thursday only-Retired GOC Member

Public PriceCAD $80

GOC Executive-CPD

Member PriceComplimentary

GOC Executive-Fellows half day

Member PriceComplimentary

Fellows half day, Thursday only- residents/medical students

Public PriceComplimentary

Fellows half day, Thursday only-Sponsors & Partners

Member PriceCAD $160

GOC Invited partner rep-CPD

Public PriceComplimentary

Speaker-CPD

Public PriceComplimentary

Speaker-Fellows half day

Public PriceComplimentary

GOC Staff-Full event

Public PriceComplimentary

Sponsor/Exhibitor representatives

Public PriceComplimentary

Sponsor/Exhibitor representatives conference dinner

Public PriceComplimentary

CPD Speaker dinner

Public PriceComplimentary

Bundle Offer: Both Days for Fellow Member

Member PriceCAD $300

Bundle Offer: Both Days for Fellow Non-Member

Public PriceCAD $350

Accommodation

ACCOMMODATION AT GOC'S CPD

We have negotiated room discounts and secured a limited number of group-rate hotel rooms. The group rate rooms are limited and available on a first-come, first-served basis. Book early for the best selection and price by clicking on the image above.


A valid credit card is required to secure a group rate. Cancellations received within 72 hours of arrival date will incur 1-night room and tax cancellation charge.


Please call The Omni King Hotel at 1-800-843-6664 and mention our group name: SGOC Continuing Prof Development.

Frequently Asked Questions

General

Do I have to be a GOC member to register for the event?

No, this GOC event is open to Non-members and GOC members.


Is the event virtual?

The CPD event is only available in an in-person format.


Does the CPD registration the Fellows half day?

No, the Fellows half day is a separate registration option.


When does the early bird pricing end?

April 16th, 2024, at 11:55pm PST.


Does the event have any social activities?

Yes, you can attend the fellows' half-day reception on May 2nd or the CPD dinner on May 3rd. Please remember to add these tickets to your registration when registering. 

Planning Committee

The members of GOC's CPD Program Planning Committee are healthcare experts from various fields with a focus on gynecologic oncology care and research. The primary objective of the committee is to represent the interests of the intended audience at CPD by ensuring that the educational content of the conference aligns with the overall goals of all internal and external stakeholders attending this conference. The committee is responsible for organizing and creating the conference content while also recruiting the required faculty members.

Susie Lau

Chair

Gynecologic Oncologist

McGill University/Sir Mortimer B. Davis Jewish General Hospital

Conflict of Interest

Joannie Neveu

Chair-Elect

Gynecologic Oncologist

Dr. H. Bliss Murphy Cancer Centre

Conflict of Interest

Helen MacKay

Member

Medical Oncologist

Odette Cancer Centre, Sunnybrook Health 

Conflict of Interest

Alon Altman

Member

Gynecologic Oncologist

CancerCare Manitoba

Conflict of Interest

Jacob McGee

Member

Gynecologic Oncologist

London Health Science Centre

Conflict of Interest coming soon

Genevieve Bouchard-Fortier

Member

Gynecologic Oncologist

Princess Margaret Cancer Centre

Conflict of Interest

Lesley Roberts

Member

Gynecologic Oncologist

CancerCare Manitoba

Conflict of Interest

Tomer Feigenberg

Member

Gynecologic Oncologist

Trillium Health Partners

Conflict of Interest

Mark Carey

Member

Gynecologic Oncologist

Vancouver Coastal Health (VCH)

Conflict of Interest

Joanne Power

Member

Advanced Practice Nurse 

McGill University Health Centre

Conflict of Interest

Rachelle Findley

Member

Gynecologic Oncologist

Nova Scotia Cancer Centre

Conflict of Interest

Cristina Mitric

Member

Fellow

University of Toronto

Conflict of Interest

Stephen Welch

Member

Medical Oncologist

Western University

Conflict of Interest 

Marie-Hélène Auclair

Member

Gynecologic Oncologist

Hôpital Maisonneuve-Rosemont

Conflict of Interest 

Omar Touhami

Member

Gynecologic Oncologist

CIUSSS du Saguenay Lac Saint Jean

Conflict of Interest

Melica Nourmoussavi Brodeur

Member

Fellow, Postdoctoral Research Memorial Sloan Kettering Cancer Center

Conflict of Interest

Laurence Bernard

Member

Fellow, Postdoctoral

MD Anderson Cancer Centre

Conflict of Interest

Yvette Drew

Member

Medical Oncologist

BC Cancer

Conflict of Interest

Sponsors & Exhibitors